Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHA:600557)
China · Delayed Price · Currency is CNY 12.72
+0.11 (0.87%)
Jul 3, 2026, 3:00 PM CST
SHA:600557 Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, SHA:600557 stock has a consensus rating of "Strong Buy" and an average price target of ¥15.66. The average 1-year stock price forecast is 23.11% higher than the current stock price, while the lowest is ¥14.00 (+10.06%) and the highest is ¥17.31 (+36.08%).
Price Target: ¥15.66 (+23.11%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SHA:600557 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Feb '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 2 | 2 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 2 | 2 | 3 |
Financial Forecast
Revenue This Year
3.45B
from 3.29B
Increased by 4.85%
Revenue Next Year
3.67B
from 3.45B
Increased by 6.40%
EPS This Year
0.90
EPS Next Year
1.02
from 0.90
Increased by 13.33%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.5B | ||
| Avg | 3.5B | ||
| Low | 3.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 6.5% | ||
| Avg | 4.8% | ||
| Low | 3.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.90 | ||
| Avg | 0.90 | ||
| Low | 0.90 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 42.9% | ||
| Avg | 42.9% | ||
| Low | 42.9% |